Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ImmuCell Corporation - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ICCC
Nasdaq
2836
immucell.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ImmuCell Corporation
Niche Focus & Regulation Shape the Future of Healthcare Firms
- Jan 15th, 2026 9:24 am
Those who invested in ImmuCell (NASDAQ:ICCC) a year ago are up 25%
- Jan 12th, 2026 6:02 am
ImmuCell Q4 Earnings Call Highlights
- Jan 9th, 2026 9:02 am
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025
- Jan 8th, 2026 2:05 pm
ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus
- Jan 7th, 2026 6:10 am
Top Stock Reports for AbbVie, Coca-Cola & Chevron
- Dec 24th, 2025 11:10 am
ImmuCell Announces Strategic Focus on First DefenseĀ® After Receiving an FDA Incomplete Letter for Re-TainĀ®
- Dec 24th, 2025 11:05 am
ImmuCell's Two-Product Edge in Cattle Health Fuels Growth
- Dec 4th, 2025 9:14 am
ImmuCell Corp (ICCC) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...
- Nov 24th, 2025 6:02 pm
ICCC Stock Down Despite Y/Y Q3 Earnings Improvement & Margin Strength
- Nov 20th, 2025 5:42 am
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025
- Nov 13th, 2025 2:05 pm
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025
- Nov 6th, 2025 2:05 pm
ImmuCell Announces Onboarding of New CEO and Related Management Changes
- Nov 4th, 2025 2:05 pm
Is ImmuCell Corporation's (NASDAQ:ICCC) Recent Price Movement Underpinned By Its Weak Fundamentals?
- Nov 1st, 2025 6:57 am
The Zacks Analyst Blog Highlights SAP, Novartis, Philip Morris International, ImmuCell and ClearOne
- Oct 9th, 2025 7:37 am
Top Stock Reports for SAP, Novartis & Philip Morris
- Oct 8th, 2025 3:07 pm
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025
- Oct 7th, 2025 2:05 pm
Calculating The Fair Value Of ImmuCell Corporation (NASDAQ:ICCC)
- Oct 2nd, 2025 6:08 am
ImmuCell Announces Selection of its Next President and CEO
- Sep 29th, 2025 2:05 pm
FONAR's Stock Advances 5% in Three Months: Key Trends Ahead
- Sep 9th, 2025 10:57 am
Scroll